After posting the worst first half of any year since 1970 (1), the stock market has come roaring back to life in Q3, with technology and risk bets leading the way following Fed Chair Jerome Powell’s signal at the July FOMC meeting of a possible shift in policy bearing. (2) The Fed believes it is […]
MDT
Recession-Proof Medical Device Space Looks Ahead at Accelerating Growth Potential (TIVC, EMED, ZBH, NVCR, MDT, ZYXI, ECOR, ISRG)
The spread of the “recession” meme is starting to reach a fever pitch (1). In this case, it could counterintuitively be a positive catalyst for the long duration side of the market – ie, the long-term growth bets that are still in their early innings, with big fireworks still to come over the next 5-10 […]
How Decentralized Healthcare Could Spawn Coming Boom in Medical Device Stocks (ECOR, EMED, NVCR, MDT, ZYXI, TIVC, ZBH, ISRG)
One group stands out as an interesting and potentially dramatically undervalued area of the market in the wake of the pandemic and its historical footprint: Medical device stocks. The healthcare system has been forever changed by the pandemic, which accelerated several core healthcare industry trends that were already poised to become important at some point […]
Medical Device Stocks in Sweet Spot as Correction Creates Historic Opportunity (MDT, EMED, ZYXI, ECOR, NVCR, TIVC, ZBH, ISRG)
One positive spin we can put on the “great growth stock bear market of 2022” – which, let’s face it, is what we are dealing with so far this year – is the value being created for future portfolio returns. We have seen indiscriminate selling in many high-growth areas of the market over the first […]
Cyberonics (NASDAQ:CYBX) Cheers on Satisfy Quarter Profit – CYBX, BSX, MDT, STJ, HOLX
Medical device maker Cyberonics, Inc. (NASDAQ:CYBX)’s shares jumped around 13% on Friday following the firm declared fiscal Q2 earnings, increased by a one-time gain, in front of estimates. Cyberonics generated 44 cents per share, increased 37 percent from the year-earlier quarter. Analysts had anticipated a profit of 39 cents per share. With Friday’s gain, shares […]
Regenicin (RGIN) Fails to Restore Recent Rally
Shares of Regenicin (OTC: RGIN) meandered throughout the day in a tight trading range that ended with the stock posting no change for the session at a price of 20 cents. Trading activity can best be described as sporadic with a tad over 1.6 million shares exchanging hands. The opening five minutes of the day […]
